Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Mathian

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
Annals of the Rheumatic Diseases|September 5, 2020
Response to 'Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic' by Chuah <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|May 31, 2020
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|July 4, 2020
Response to: 'Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey' by Plüß <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|April 12, 2020
Response to: 'Comments on the article: "Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial"' by Mousavi and TaherifardAlexis Mathian, Micheline Pha, Zahir Amoura
Annals of the Rheumatic Diseases|April 4, 2020
Response to: 'Glucocorticoid withdrawal in lupus: to do or not to do?' by AcharyaAlexis Mathian, Micheline Pha, Zahir Amoura
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 22, 2016
Panitumumab-Induced Immune Complex GlomerulonephritisHassan Izzedine, Haide Boostandoost, Alexis Mathian
Autoimmunity Reviews|October 10, 2006
Type-I interferons and systemic lupus erythematosusSophie Koutouzov, Alexis Mathian, Ali Dalloul
Annals of the Rheumatic Diseases|May 9, 2020
Response to: 'Withdrawal of low-dose prednisone in inactive SLE patients: is there another alternative?' by SabioAlexis Mathian, Micheline Pha, Zahir Amoura
La Revue Du Praticien|February 8, 2012
[When to think about lupus?]Laurent Arnaud, Alexis Mathian, Zahir Amoura
Current Opinion in Rheumatology|June 12, 2018
Lupus and vaccinationsAlexis Mathian, Micheline Pha, Zahir Amoura
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
Annals of the Rheumatic Diseases|September 5, 2020
Response to 'Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic' by Chuah <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|May 31, 2020
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|July 4, 2020
Response to: 'Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey' by Plüß <i>et al</i>Alexis Mathian, Zahir Amoura
Annals of the Rheumatic Diseases|April 12, 2020
Response to: 'Comments on the article: "Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial"' by Mousavi and TaherifardAlexis Mathian, Micheline Pha, Zahir Amoura
Annals of the Rheumatic Diseases|April 4, 2020
Response to: 'Glucocorticoid withdrawal in lupus: to do or not to do?' by AcharyaAlexis Mathian, Micheline Pha, Zahir Amoura
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 22, 2016
Panitumumab-Induced Immune Complex GlomerulonephritisHassan Izzedine, Haide Boostandoost, Alexis Mathian
Autoimmunity Reviews|October 10, 2006
Type-I interferons and systemic lupus erythematosusSophie Koutouzov, Alexis Mathian, Ali Dalloul
Annals of the Rheumatic Diseases|May 9, 2020
Response to: 'Withdrawal of low-dose prednisone in inactive SLE patients: is there another alternative?' by SabioAlexis Mathian, Micheline Pha, Zahir Amoura
La Revue Du Praticien|February 8, 2012
[When to think about lupus?]Laurent Arnaud, Alexis Mathian, Zahir Amoura
Current Opinion in Rheumatology|June 12, 2018
Lupus and vaccinationsAlexis Mathian, Micheline Pha, Zahir Amoura
Pageof 22